+ Site Statistics
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

Inhibitors of fatty acid oxidation

Inhibitors of fatty acid oxidation

Life Sciences 40(15): 1443-1449

This review considers inhibitors of fatty acid oxidation for which sites and mechanisms of inhibition are reasonably well understood.

Accession: 001619772

Download citation: RISBibTeXText

PMID: 3550347

DOI: 10.1016/0024-3205(87)90375-4

Download PDF Full Text: Inhibitors of fatty acid oxidation

Related references

Prostaglandin and fatty acid q- and (q-1)-oxidation in rabbit lung. Acetylenic fatty acid mechanism-based inactivators as specific inhibitors. The Journal of Biological Chemistry 264: 9-56, 1989

HIV-protease inhibitors suppress skeletal muscle fatty acid oxidation by reducing CD36 and CPT1 fatty acid transporters. Biochimica et Biophysica Acta 1801(5): 559-566, 2010

Inhibitors of fatty acid oxidation and the pathway of fatty acid biosynthesis from glucose. Metabolic inhibitors a comprehensive treatise: 311-347, 1973

Isozyme-nonselective N-substituted bipiperidylcarboxamide acetyl-CoA carboxylase inhibitors reduce tissue malonyl-CoA concentrations, inhibit fatty acid synthesis, and increase fatty acid oxidation in cultured cells and in experimental animals. Journal of Biological Chemistry 278(39): 37099-37111, 2003

Fatty acid incubation of myotubes from humans with type 2 diabetes leads to enhanced release of beta-oxidation products because of impaired fatty acid oxidation: effects of tetradecylthioacetic acid and eicosapentaenoic acid. Diabetes 58(3): 527-535, 2008

Fatty Acid Incubation of Myotubes From Humans With Type 2 Diabetes Leads to Enhanced Release of beta-Oxidation Products Because of Impaired Fatty Acid Oxidation Effects of Tetradecylthioacetic Acid and Eicosapentaenoic Acid. 2009

Prostaglandin and fatty acid omega- and (omega-1)-oxidation in rabbit lung. Acetylenic fatty acid mechanism-based inactivators as specific inhibitors. Journal of Biological Chemistry 264(2): 749-756, 1989

Effect of the fatty acid oxidation inhibitor 2-tetradecylglycidic acid (TDGA) on glucose and fatty acid oxidation in isolated rat soleus muscle. International Journal of Biochemistry 20(2): 155-160, 1988

Fatty acid oxidation inhibitors. LeRoith, D, Taylor, S I, Olefsky, J M Diabetes mellitus: A fundamental and clinical text 668-674, 1996

Inhibitors of fatty acid oxidation (Mercaptoacetate, R-3-amino-4-trimethylaminobutyric acid) stimulate feeding in mice. Physiology and Behavior 63(5): 751-754, 1998

On the rate-determining step of fatty acid oxidation in heart. Inhibition of fatty acid oxidation by 4-pentenoic acid. Journal of Biological Chemistry 253(19): 6917-6922, 1978

New Developments in Fatty Acid Oxidation. Proceedings of the 2nd International Symposium on Clinical, Biochemical, and Molecular Aspects of Fatty Acid Oxidation. Philadelphia, Pennsylvania, November 1991. Progress in Clinical and Biological Research 375: 1-595, 1992

Mitochondrial fatty acid oxidation disorders: clinical presentation of long-chain fatty acid oxidation defects before and after newborn screening. Journal of Inherited Metabolic Disease 33(5): 527-532, 2011